Drugs / RIG-C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02139657 | Mar → May 2014 | rabies | Grifols Therapeutics LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RIG-C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02139657 ↗ |
| Route | Intramuscular | “single 20 IU/kg intramuscular (IM) dose of RIG-C” PMID 29983597 ↗ Jun 2018 |